BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kardani K, Bolhassani A. Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches. PLoS One 2021;16:e0247396. [PMID: 33606823 DOI: 10.1371/journal.pone.0247396] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Guo X, Chen L, Wang L, Geng J, Wang T, Hu J, Li J, Liu C, Wang H. In silico identification and experimental validation of cellular uptake and intracellular labeling by a new cell penetrating peptide derived from CDN1. Drug Deliv 2021;28:1722-36. [PMID: 34463179 DOI: 10.1080/10717544.2021.1963352] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Sadiq IZ, Muhammad A, Mada SB, Ibrahim B, Umar UA. Biotherapeutic effect of cell-penetrating peptides against microbial agents: a review. Tissue Barriers 2021;:1995285. [PMID: 34694961 DOI: 10.1080/21688370.2021.1995285] [Reference Citation Analysis]
3 Porto WF. Virtual screening of peptides with high affinity for SARS-CoV-2 main protease. Comput Biol Med 2021;133:104363. [PMID: 33862305 DOI: 10.1016/j.compbiomed.2021.104363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Porosk L, Põhako K, Arukuusk P, Langel Ü. Cell-Penetrating Peptides Predicted From CASC3, AKIP1, and AHRR Proteins. Front Pharmacol 2021;12:716226. [PMID: 34504427 DOI: 10.3389/fphar.2021.716226] [Reference Citation Analysis]
5 Wylie B, Ong F, Belhoul-Fakir H, Priebatsch K, Bogdawa H, Stirnweiss A, Watt P, Cunningham P, Stone SR, Waithman J. Targeting Cross-Presentation as a Route to Improve the Efficiency of Peptide-Based Cancer Vaccines. Cancers (Basel) 2021;13:6189. [PMID: 34944809 DOI: 10.3390/cancers13246189] [Reference Citation Analysis]
6 Singh N, Villoutreix BO. Resources and computational strategies to advance small molecule SARS-CoV-2 discovery: Lessons from the pandemic and preparing for future health crises. Comput Struct Biotechnol J 2021;19:2537-48. [PMID: 33936562 DOI: 10.1016/j.csbj.2021.04.059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gao K, Wang R, Chen J, Cheng L, Frishcosy J, Huzumi Y, Qiu Y, Schluckbier T, Wei X, Wei GW. Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2. Chem Rev 2022. [PMID: 35594413 DOI: 10.1021/acs.chemrev.1c00965] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Herrera R, Rosbe K, Tugizov SM. Inactivation of HIV-1 in Polarized Infant Tonsil Epithelial Cells by Human Beta-Defensins 2 and 3 Tagged with the Protein Transduction Domain of HIV-1 Tat. Viruses 2021;13:2043. [PMID: 34696473 DOI: 10.3390/v13102043] [Reference Citation Analysis]